Statin use improves outcomes in HCC patients after liver transplantAugust 27, 2021Hepatocellular Carcinoma
Baseline albumin-bilirubin and alpha-fetoprotein predict treatment response in HCCAugust 27, 2021Hepatocellular Carcinoma
MRI-targeted biopsy equals standard biopsy for detecting prostate cancerJuly 28, 2021Hepatocellular Carcinoma
High-dose-rate brachytherapy improves quality of life in prostate cancerJuly 28, 2021Hepatocellular Carcinoma
Enzalutamide tops abiraterone acetate for progression-free survival in metastatic prostate cancerJuly 28, 2021Hepatocellular Carcinoma
Black men may have an increased risk of prostate cancer progression on active surveillanceJuly 28, 2021Hepatocellular Carcinoma
Inflammatory response in prostate cancer shows variation by ethnicityJuly 28, 2021Hepatocellular Carcinoma
Docetaxel demonstrates stronger safety and survival profile than cabazitaxel for prostate cancerJuly 28, 2021Hepatocellular Carcinoma
Active surveillance does not impair quality of life in low-risk prostate cancerJuly 28, 2021Hepatocellular Carcinoma
Platelet-to-lymphocyte ratio fails to predict prostate cancer at biopsyJuly 28, 2021Hepatocellular Carcinoma
IBD patients with prostate cancer may benefit from radiation therapyJuly 28, 2021Hepatocellular Carcinoma
Liver resection yields limited success in HCC patients with hepatitis B/C coinfectionJuly 26, 2021Hepatocellular Carcinoma
